Phase II study of two eribulin regimens in combination with erlotinib in patients (pts) with previously treated advanced non-small cell lung cancer (NSCLC)

Abstract: 2537
Congress: ESMO 2012
Type: Abstract
Topic: NSCLC, locally advanced
Authors: S. Geater1, N. Ianotti2, S. Thongprasert3, A. Spira4, D. Smith4, V. Lee5, W.T. Lim6, P. Gopalakrishna7, C. Reynolds4, T. Mok5; 1Hatyai Songkhla/Thailand, 2Port Saint Lucie, FL/United States of America, 3Chiangmai/Thailand, 4Houston, TX/United States of America, 5Hong Kong/China, 6Singapore/Singapore, 7Hatfield/United Kingdom